In two separate cases announced together in August 2021, the U.S. Attorney's Office for the District of Colorado said it had held nurses accountable for taking controlled substances from the patients in their care. The office described the conduct as theft of medications from suffering patients.

The cases were investigated by the FDA Office of Criminal Investigations and the DEA, working with federal prosecutors in Denver. The release credits that investigative work with bringing the diversion to light and stopping it.

The press release does not identify the facilities, the specific drugs taken, or the sentences imposed in each case. It states that the theft of medications from patients in these cases has been stopped.